JM Schenk, AR Kristal, KB Arnold… - American Journal of …, 2011 - Oxford Univ Press This study examined the association between symptomatic benign prostatic hyperplasia (BPH) and prostate cancer risk in 5,068 placebo-arm participants enrolled in the Prostate Cancer Prevention Trial (1993–2003). These data include 1,225 men whose cancer was detected ... Cited by 2 - Related articles - All 4 versions
Y Chen, SW Fine… - The American Journal of Surgical …, 2011 - journals.lww.com Mesonephric remnant hyperplasia is a very rare benign mimicker of prostate adenocarcinoma. As most reported cases are from transurethral resection specimens, the anatomic location and histologic spectrum of this entity have not been fully elucidated. Its ... Related articles - All 2 versions
C De Nunzio, G Kramer, M Marberger, R Montironi… - European Urology, 2011 - Elsevier The histologic signature of chronic inflammation is a common finding in benign and malignant prostate tissue. The inflammatory infiltrates are mainly represented by CD3 + T lymphocytes (70–80%, mostly CD4), CD19 or CD20 B lymphocytes (10–15%), and macrophages ... Cited by 3 - Related articles - All 2 versions
DD Ørsted, SE Bojesen, SF Nielsen… - European Urology, 2011 - Elsevier Using designs with individual participant data from five national registries, we studied the entire Danish male population from 1980 through 2006, a total of 3 009 258 Danish men. We collected PCa diagnoses (n = 53 315), information on PCa mortality (n = 25 459), and ascertained ... Cited by 2 - Related articles - All 2 versions
ME Duncan… - BJU international, 2011 - Wiley Online Library RESULTS In the Oxford region, underlying-cause mortality from BPH fell from 45 deaths per million in 1979 to 2.4 in 2006. For mentions, the respective rates were 93 and 7.1. In England, underlying-cause mortality reduced from 9.2 deaths per million in 1995 to 4.5 ... Cited by 1 - Related articles - All 5 versions